Clinical trial
A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia
NCT00209950 · H. Lundbeck A/S, Industry · Completed
Key facts
| NCT number | NCT00209950 |
|---|---|
| Title | A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia |
| Official title | A Prospective Open-Label Extension Study (to Study 99784) of Gaboxadol in Primary Insomnia |
| Lead sponsor | H. Lundbeck A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Primary Insomnia |
| Intervention type | Drug |
| Interventions | Gaboxadol |
| Enrollment | 200 |
| Start date | Jul 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Mar 30, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: